October 4-5, 2018 | Boston, MA
Pre-Conference Workshop Days | October 2-3, 2018

  Save $500 On Your Attendance

 

Addressing Challenges to Implementation of Broad Biomarker Testing in Oncology

Wednesday October 3 | 1:30pm – 5pm

Comprehensive Genomic Profiling (CGP) diagnostics have arrived into oncology mainstream, with high profile approvals of companion diagnostics capturing the imagination in 2017. However, the real-world application of this testing still presents challenges – improvements to workflow, reporting, and harmonization are still needed to ensure the benefits of CGP reach appropriate patients.

Streamlining existing CGP workflows will shorten the duration from biopsy to results – an essential step in advancing the utility of CGP diagnostics. In addition, as utilization of CGP increases, so will the importance of simplification and standardization of reporting metrics.

Please Join Bristol-Myers Squibb and their expert panel of speakers in this interactive and in-depth workshop, as these leaders in the field discuss and brainstorm potential solutions to these complex considerations.

Key themes

  • What is preventing CGP from reaching all appropriate cancer patients
  • How can we streamline pre-analytical workflows to reduce turnaround
  • How can we standardize reporting to improve transferability and reproducibility